Navigation Links
PRA International Expert to Chair Panel at Partnerships Conference

RALEIGH, N.C., Nov. 15, 2010 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that one of its experts will lead a panel at the 9th annual Partnerships in Clinical Trials conference in Vienna, Austria from 17-18 November 2010. PRA, a co-sponsor of the conference, will exhibit at booth 209.

Dr. Susan Stansfield, Executive Vice President of PRA's Product Registration group for Europe, Africa and Asia-Pacific, will chair the "Improving Project Management in Your Clinical Partnerships" program on opening day. This breakout stream will review performance management strategies, sponsor engagement, relationship management, and other topics. The sessions will also feature a project management clinic and an interactive panel discussion.

At our booth, PRA representatives, including members of our European leadership team, will be available to discuss PRA's approach to partnerships and clinical development projects.

Dr. Stansfield has an extensive industry background spanning nearly 20 years, having served in senior management positions at several clinical research organizations before joining PRA in 2007. Her experience includes running full-service clinical research programs, managing business process improvements, and leading entire organizational units in clinical development.

For more information about the Partnerships in Clinical Trials event, please visit and click on "Events."

About PRA International

PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 3000 clinical trials through its 38 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit, email or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results
2. Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group
3. Dehaier Medical to Participate in MEDICA International Trade Fair
4. Microfluidics International Corporation to Report Third Quarter 2010 Financial Results on November 16, 2010
5. Systech International and Vantage Consulting Group Partner to Address Emerging U.S. Pharmaceutical Regulatory Requirements
6. PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston
7. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
8. International Medical Corps Mobilizes Teams, Supplies Across Haiti in Preparation for Tropical Storm Tomas
9. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
10. Saudi Arabias King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy
11. International Isotopes Inc. Announces Completion of a $5.8 Million Private Placement
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... On November 25, 2015, officials of Narconon Arrowhead ... the release of a new cutting edge recovery program that has been 50 years ... drug- and alcohol-addicted individuals with the purpose to free addicts from the symptoms and ...
(Date:11/25/2015)... ... ... The McHenry County law firm of Botto Gilbert Lancaster, PC ... Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant David Adcock ... , According to court documents, Adcock testified that on May 10, 2010 he sat ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased to ... facial wrinkling. While many patients are aware of the benefits of Botox® in the ... to those suffering with discomfort, soreness, and pain as a result of Jaw Tension, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android app ... new app features a more intuitive SleepScore™ that rates sleep quality on a 100-point ... SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide an ...
(Date:11/25/2015)... , ... November 25, 2015 , ... In an ongoing ... Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its ... surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 at ...
Breaking Medicine News(10 mins):